Catecholamine-induced cardiac hypertrophy in rats is associated with the activation of p70S6 kinase and c-Jun NH2-terminal kinase 2

Experimental and Clinical Cardiology

Volumn 7, Issue 2-3, 2002, Pages 131-137

  Leicht, Monika ^a   Greipel, Nora ^a   Raßler, Beate ^a   Zimmer, Heinz Gerd ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

c Jun NH2 terminal kinase; Catecholamines; Hypertrophy; Rat; Ribosomal S6 kinase

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE P38; NORADRENALIN; PHENYLEPHRINE; PHOSPHORUS 32; PRAZOSIN; PROPRANOLOL; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; BETA ADRENERGIC STIMULATION; BODY WEIGHT; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FEMALE; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0036768135     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Irlbeck M, Mühling O, Iwai T, Zimmer HG. Different response of the rat left and right heart to norepinephrine. Cardiovasc Res 1996;31:157-62.
2. Barth W, Deten A, Bauer M, Reinohs M, Leicht M, Zimmer HG. Differential remodeling of the left and right heart after norepinephrine treatment in rats: Studies on cytokines and collagen. J Mol Cell Cardiol 2000;32:273-84.
3. Zierhut W, Zimmer HG. Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 1989;65:1417-25.
4. 1 adrenergic response. J Clin Invest 1983;72:732-8.
5. Lee HR, Henderson SA, Reynolds R, Dunnmon P, Yuan D, Chien KR. Alpha 1-adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression. J Biol Chem 1988;263:7352-8.
6. Simpson PC, Long CS, Waspe LE, Henrich CJ, Ordahl CP. Transcription of early developmental isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol 1989;21(Suppl 5):79-89.
7. Knowlton KU, Michel MC, Itani M, et al. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 1993;268:15374-80.
8. Karliner JS, Kariya T, Simpson PC. Effects of pertussis toxin on alpha1-agonist-mediated phosphatidylinositide turnover and myocardial cell hypertrophy in neonatal rat ventricular myocytes. Experientia 1990;46:81-4.
9. Yamazaki T, Komuro I, Zou Y, et al. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1- and beta-adrenoceptors. Circulation 1997;95:1260-8.
10. Yamazaki T, Komuro I, Zou Y, et al. Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat cardiomyocytes. J Mol Cell Cardiol 1997;29:2491-501.
11. Thorburn J, McMahon M, Thorburn A. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J Biol Chem 1994;269:30580-6.
12. Fuller SJ, Finn SG, Downward J, Sugden PH. Stimulation of gene expression in neonatal rat ventricular myocytes by Ras is mediated by Ra1 guanine nucleotide dissociation stimulator (Ra1.GDS) and phosphatidylinositol 3-kinase in addition to Raf. Biochem J 1998;335:241-6.
13. Minden A, Lin A, McMahon M, et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994;266:1719-23.
14. Ramirez MT, Sah VP, Zhao XL, Hunter JJ, Chien KR, Brown JH. The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem 1997;272:14057-61.
15. Choukroun G, Hajjar R, Fry S, et al. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. J Clin Invest 1999;104:391-8.
16. Boluyt MO, Zheng JS, Younes A, et al. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ Res 1997;81:176-86.
17. Simm A, Schluter K, Diez C, Piper HM, Hoppe J. Activation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes. J Mol Cell Cardiol 1998;30:2059-67.
18. Allard MF, DeVenny MF, Doss LK, Grizzle WE, Bishop SP. Alterations in dietary sodium affect isoproterenol-induced cardiac hypertrophy. J Mol Cell Cardiol 1990;22:1135-45.
19. Jefferies HB, Reinhard C, Kozma SC, Thomas G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA 1994;91:4441-5.
20. Terada N, Patel HR, Takase K, Kohno K, Nairn AC, Gelfand EW. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 1994;91:11477-81.
21. Sadoshima J, Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res 1995;77:1040-52.
22. Takano H, Komuro I, Zou Y, Kudoh S, Yamazaki T, Yazaki Y. Activated of p70 S6 protein kinase is necessary for angiotensin II-induced hypertrophy in neonatal rat cardiac myocytes. FEBS Lett 1996;379:255-9.
23. Giasson E, Meloche S. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J Biol Chem 1995;270:5225-31.
24. Leicht M, Simm A, Bertsch G, Hoppe J. Okadaic acid induces cellular hypertrophy in AKR-2B fibroblasts: Involvement of the p70S6 kinase in the onset of protein and rRNA synthesis. Cell Growth Differ 1996;7:1199-209.
25. Baliga RR, Pimentel DR, Zhao YY, et al. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am J Physiol 1999;277:H2026-37.
26. Schluter KD, Simm A, Schafer M, Taimor G, Piper HM. Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am J Physiol 1999;276:H1655-63.
27. Simm A, Nestler M, Hoppe V. PDGF-AA, a potent mitogen for cardiac fibroblasts from adult rats. J Mol Cell Cardiol 1997;29:357-68.
28. Vinals F, Chambard JC, Pouyssegur J. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J Biol Chem 1999;274:26776-82.
29. Zimmer HG, Ibel H, Suchner U. Beta-adrenergic agonists stimulate the oxidative pentose phosphate pathway in the rat heart. Circ Res 1990;67:1525-34.
30. Bartolome J, Huguenard J, Slotkin TA. Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science 1980;210:793-4.
31. Wang Y, Su B, Sah VP, Brown JH, Han J, Chien KR. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a speciic activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 1998;273:5423-6.
32. Lazou A, Sugden PH, Clerk A. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKS) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart. Biochem J 1998;332:459-65.
33. Vogel V, Bokemeyer D, Heller J, Kramer HJ. Cardiac hypertrophy in the Prague hypertensive rat is associated with enhanced JNK2 but not ERk tissue activity. Kidney Blood Press Res 2001;24:52-6.
34. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res 1996;78:954-61.
35. Pinson A, Schluter KD, Zhou XJ, Schwairtz P, Kessler-Icekson G, Piper HM. Alpha- and beta-adrenergic stimulation of protein synthesis in cultured adult ventricular cardiomyocytes. J Mol Cell Cardiol 1993;25:477-90.
36. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992;262:H1861-6.
37. Wunsch M, Sharma HS, Markert T, et al. In situ localization of transforming growth factor beta 1 in porcine heart: Enhanced expression after chronic coronary artery constriction. J Mol Cell Cardiol 1991;23:1051-62.
38. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 1995;92:4862-6.
39. Pan J, Fukuda K, Kodama H, et al. Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels 1998;13:199-208.
40. Kunisada K, Negoro S, Tone E, et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA 2000;97:315-9.
41. Briest W, Hölzl A, Raßler B, et al. Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc Res 2001;52:265-73.